Bortezomib will enhance the amount or impact of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Improved flibanserin adverse consequences could manifest if coadministered with multiple weak CYP3A4 inhibitors. Other results, like a skin rash, might not be really serious but may trigger problem. Some consequences https://myelinoligodendrocyteglyc69998.blogginaway.com/27285636/what-does-retene-mean